Frontiers | Methods on LDL particle isolation, characterization, and component fractionation for the development of novel specific oxidized LDL status markers for atherosclerotic disease risk assessment
![PDF] The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/deba401d9761b90d6afcfe7d2fe0f0d0f0da448f/3-Figure1-1.png "PDF] The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease | Semantic Scholar")
PDF] The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease | Semantic Scholar
PDF) Markers of increased cardiovascular risk in patients with chronic kidney disease
Full article: Elevated soluble LOX-1 predicts risk of first-time myocardial infarction
Prevention, diagnosis and treatment of atherosclerosis – Pathology
Obesity and chronic kidney disease | American Journal of Physiology-Endocrinology and Metabolism
Cells | Free Full-Text | High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives
Clinical Update: Cardiovascular Disease in Diabetes Mellitus | Circulation
Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease | Aging
![PDF] Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b2d8dd1950371360aa5e4be3f1697fcdd27dd8c2/4-Figure2-1.png "PDF] Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies. | Semantic Scholar")
PDF] Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies. | Semantic Scholar
Nutrition, atherosclerosis, arterial imaging, cardiovascular risk stratification, and manifestations in COVID-19 framework: a narrative review
The Role of Nutraceuticals in Statin Intolerant Patients | Journal of the American College of Cardiology
PDF) Impact of Sex Differences and Diabetes on Coronary Atherosclerosis and Ischemic Heart Disease | Salvatore De Rosa - Academia.edu
Lp-PLA2, a new biomarker of vascular disorders in metabolic diseases - Alessandro De Stefano, Liliana Mannucci, Federica Tamburi, Carmine Cardillo, Francesca Schinzari, Valentina Rovella, Steven Nisticò, Luigi Bennardo, Nicola Di Daniele, Manfredi
Prevention and Treatment of Atherosclerosis: The Use of Nutraceuticals and Functional Foods | SpringerLink
HDL abnormalities in type 2 diabetes: Clinical implications
2020 Guidelines of the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA) on laboratory diagnostics of lipid metabolism disorders
Novel oxidized LDL-based clinical markers in peritoneal dialysis patients for atherosclerosis risk assessment - ScienceDirect
Nutrition, atherosclerosis, arterial imaging, cardiovascular risk stratification, and manifestations in COVID-19 framework: a narrative review
Deletion of bone marrow myeloperoxidase attenuates chronic kidney disease accelerated atherosclerosis - ScienceDirect
Erratum to: Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study
Cholesterol Metabolism in CKD. - Abstract - Europe PMC
